Home > Financial Ratios > SMS PHARMACEUTICALS

SMS PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
SMS PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SMS PHARMACEUTICALS
Please provide your vote to see the results

SMS PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 103.90-50.38-3.8346.34-8.99

What is the latest Core EBITDA Growth ratio of SMS PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of SMS PHARMACEUTICALS is 103.90 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024103.90
Mar2023-50.38
Mar2022-3.83
Mar202146.34
Mar2020-8.99

How is Core EBITDA Growth of SMS PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2024 103.9
Positive
Mar2023 -50.38
Negative
Mar2022 -3.83
Negative
Mar2021 46.34
Positive
Mar2020 -8.99 -

Other Financial Ratios of SMS PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of SMS PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS ₹1,815.5 Cr 11.2% 4.6% 39.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,223.0 Cr -4.1% -9.8% 8.2% Stock Analytics
DIVIS LABORATORIES ₹152,610.0 Cr -2.9% -0.3% 63.8% Stock Analytics
CIPLA ₹119,067.0 Cr 0.1% 4.4% 2.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹102,744.0 Cr -1.3% -6.5% 19% Stock Analytics
DR REDDYS LABORATORIES ₹96,123.8 Cr -4% -5.9% -7.8% Stock Analytics


SMS PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS

11.2%

4.6%

39.6%

SENSEX

-0.8%

-1.6%

3.1%


You may also like the below Video Courses